Sponsored Content

A new way to manage treatment-resistant depression

Sponsored by
a woman looks back over her shoulder and smiles

Unlike ketamine treatments, Spravato, an esketamine nasal spray, is FDA-approved and covered by insurance.

Photo via Unsplash

Did you know there’s an FDA-approved nasal spray that can help adults with treatment-resistant depression? Spravato, the game-changing medication, can be prescribed for adults diagnosed with treatment-resistant depression (defined as not having experienced sufficient relief from two or more antidepressants).

The local experts at Active Path Mental Health are on hand to help Portlanders who might benefit from adding Spravato to their wellness toolbox. Pro tip: It’s covered by most insurance plans. Schedule a free consultation to see if this treatment is right for you. Learn more.

More from PDXtoday